INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 46h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

74,179 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
RE
Reginelli EdwardChief Financial Officer
BTGOBITGO HOLDINGS, INC.
Tax withholding
F$642
88 sh
Sep 6, 2026Sep 9, 2026
Page 458 of 1855
← PrevNext →
traded Sep 6, 2026
+3d
SEC Form 4

Evidence

11
MJ
Mettler JodyChief Operating Officer
BTGOBITGO HOLDINGS, INC.
Tax withholding
F$526
72 sh
Sep 6, 2026Sep 9, 2026
traded Sep 6, 2026
+3dSEC Form 4

Evidence

11
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Tax withholding
F$17K
330 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

11
FC
Fang ChenDirector, Chief Revenue Officer
BTGOBITGO HOLDINGS, INC.
Tax withholding
F$1,606
220 sh
Sep 6, 2026Sep 9, 2026
traded Sep 6, 2026
+3dSEC Form 4

Evidence

11
AK
Akgonul Rifat KerimChief Product Officer
PEGAPEGASYSTEMS INC
Tax withholding
F$29K
782 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

11
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Option exercise
M—
718 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

11
CM
Craddock John Mitchell Jr.Chief Operating Officer
SBSISOUTHSIDE BANCSHARES INC
Tax withholding
F$4,366
133 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

11
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Option exercise
M—
558 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

11
BJ
Barry JamesEVP, President, LSG
BIOBIO.BBIO-RAD LABORATORIES, INC.
Grant or award
A—
4,313 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

11
FA
Fashinpaur Melissa AChief Accounting Officer
MTRNMATERION Corp
Grant or award
A—
1 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

11
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Tax withholding
F$14K
271 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

11
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$206K
4,758 sh
Sep 9, 2026Sep 9, 2026
traded Sep 9, 2026
+0dSEC Form 4

Evidence

11
AK
Akgonul Rifat KerimChief Product Officer
PEGAPEGASYSTEMS INC
Option exercise
M—
2,202 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

11
AK
Akgonul Rifat KerimChief Product Officer
PEGAPEGASYSTEMS INC
Tax withholding
F$40K
1,065 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

11
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$131K
3,056 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

11
MA
Modi Rajeev A.SEE REMARKS
ELANElanco Animal Health Inc
Grant or award
A$1,477
60 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

11
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Tax withholding
F$12K
226 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

11
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Option exercise
M—
677 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

11
WJ
Wassil JimEVP, Chief Scientific Ofc, COO
PCVXVaxcyte, Inc.
Tax withholding
F$330K
5,459 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

11
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Tax withholding
F$18K
350 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

11
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Option exercise
M—
463 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

11
EA
Engelhardt Eva AnetteEVP, President, CDG
BIOBIO.BBIO-RAD LABORATORIES, INC.
Grant or award
A—
4,313 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

11
AK
Akgonul Rifat KerimChief Product Officer
PEGAPEGASYSTEMS INC
Option exercise
M—
1,616 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

11
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Tax withholding
F$977
463 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

11
WT
Wettig ThaneDirector, CEO
KYNBKYNTRA BIO, INC.
Tax withholding
F$1,787
209 sh
Sep 6, 2026Sep 9, 2026
traded Sep 6, 2026
+3dSEC Form 4

Evidence

11
ZD
Zugelder DanEVP, Chief Revenue Officer
DTDynatrace, Inc.
Option exercise
M—
2,808 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

10
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$3.52M
36.0K sh
Sep 9, 2026Sep 9, 2026
traded Sep 9, 2026
+0dSEC Form 4

Evidence

10
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$3.67M
37.0K sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

9
YA
Yeh Kuanling AmyChief Technology Officer
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$36K
3,000 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

9
MM
Milum Dwayne MSVP & Controller
WMTWalmart Inc.
Tax withholding
F$13K
121 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

9
DS
Dallaire SethExecutive Vice President
WMTWalmart Inc.
Tax withholding
F$41K
387 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

9
AA
Albertini AndreaCEO, Global Dist. & Tech.
HSICHENRY SCHEIN INC
Disposition to issuer
D—
3,984 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

9
HG
Higgins John GerardChief, Client &Partner Success
PEGAPEGASYSTEMS INC
Option exercise
M—
2,280 sh
Sep 7, 2026Sep 9, 2026
traded Sep 7, 2026
+2dSEC Form 4

Evidence

9
HT
Hickey ToniCLO and Corporate Secretary
VMIVALMONT INDUSTRIES INC
Grant or award
A—
310 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

9
SH
Speir Thomas HardawayEVP, CFO
UCBUNITED COMMUNITY BANKS INC
Grant or award
A—
12.8K sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

9
EA
Elimelech ArikEVP HR & Organization
ZIMZIM Integrated Shipping Services Ltd.
Option exercise
M—
3,173 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

9
OS
Ory Daniel ScottEVP, Chief Medical Officer
EDITEditas Medicine, Inc.
Grant or award
A—
950.0K sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

9
CE
Cowan ElviaSVP, Finance & CAO
PCVXVaxcyte, Inc.
Tax withholding
F$80K
1,327 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

9
HG
Higgins John GerardChief, Client &Partner Success
PEGAPEGASYSTEMS INC
Tax withholding
F$48K
1,273 sh
Sep 7, 2026Sep 9, 2026
traded Sep 7, 2026
+2dSEC Form 4

Evidence

9
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Other acquisition or disposition
J—
5.00M sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence